NIH Challenges seeks rapid, low-cost, one-step drug testing devices able to definitively detect and quantify multiple drugs, including fentanyl, from diverse samples in under 15 minutes.
NIDA seeks to support shared drug-development infrastructure to help academic and biotech researchers repurpose medications for substance use disorders and advance them toward clinical development.
This grant funds research on drug use behaviors, prevention, and health services by analyzing existing social science, behavioral, and neuroimaging data.
Use existing data to analyze drug use behaviors, prevention strategies, and service utilization, aiming to advance substance use research.
This grant funds research to develop faster, more accurate drug susceptibility tests for tuberculosis and non-tuberculous mycobacterial infections to improve treatment and combat rising drug resistance.
NIH supports discovery of in vivo chemical probes for novel brain targets, with applicants expected to have validated starting compounds and bioassays; clinical trials are not allowed.